Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of ascorbic acid with NAB-paclitaxel protein-bound, cisplatin, and gemcitabine in pancreatic cancer…
-
CLINICAL_TRIALS trial_result · 2026-07-21Clinical Trial Results: Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer [Phase 2]
Phase 2 clinical trial evaluating paclitaxel protein-bound plus gemcitabine, cisplatin, and hydroxychloroquine as treatment for untreated pa…
-
CLINICAL_TRIALS trial_result · 2026-07-13Clinical Trial Results: A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
Phase 1/2 trial results for TC-510 in advanced mesothelin-expressing cancers were terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-07-08Clinical Trial Results: Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy [NA]
A completed clinical trial comparing hand therapy intervention to traditional occupational therapy for preventing chemotherapy-induced perip…
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer [Phase 2]
Phase 2 trial assessing standard-of-care chemotherapy with or without stereotactic body radiation therapy for oligometastatic pancreatic can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery [Phase 1]
Phase 1 trial evaluating a vaccine therapy in combination with sargramostim for locally advanced pancreatic cancer that cannot be removed su…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Pre-operative Treatment for Patients With Untreated Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant, pre-operative treatment for untreated pancreatic cancer, including both resectable and unresectable di…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: The Impact Of Tissue Micro-RNA Profile From EUS-FNA In Pancreatic Adenocarcinoma
This clinical trial update reports results from a study evaluating tissue micro-RNA profiles from endoscopic ultrasound-guided fine-needle a…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating cord blood-derived CAR-NK cells in gastric cancer and pancreatic adenocarcinoma has completed status and…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: EUS-guided PORtal Vein Sampling for Circulating Tumor Cells in Pancreatic Cancer Patients [NA]
Clinical trial evaluating endoscopic ultrasound-guided portal vein sampling for circulating tumor cells in pancreatic cancer patients has co…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer [Phase 1]
Phase 1 clinical trial updates are evaluating combinations of Anetumab Ravtansine with Nivolumab, or with Nivolumab plus Ipilimumab, and wit…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial evaluating BMS-986340 as monotherapy and in combination with nivolumab or docetaxel across several advanc…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy
A completed multicenter study verifying predictive biomarkers for pancreatic cancer treatment using liquid biopsy.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of LEE011 (ribociclib) and everolimus in patients with metastatic pancreatic adenocarc…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer [Phase 1]
Phase 1 clinical trial evaluating the combination of binimetinib and hydroxychloroquine for KRAS-mutant metastatic pancreatic cancer has com…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma [Phase 2]
Phase 2 trial evaluating stereotactic body radiotherapy in combination with a focal adhesion kinase (FAK) inhibitor for advanced pancreatic …
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery [Phase 1, Phase 2]
A Phase 1/2 trial of panitumumab-IRDye800 in pancreatic adenocarcinoma patients undergoing surgery is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer [Phase 2]
Phase 2 study of zolbetuximab (IMAB362) in adults with pancreatic cancer is active but not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types [Phase 1, Phase 2]
This update reports a Phase 1/2 trial of atezolizumab plus tivozanib in several immunologically cold tumor types, with the study currently s…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy
Terminated clinical trial evaluating the clinical utility of selected circulating tumor DNA assays in patients with advanced malignancies, s…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial assessing paricalcitol and hydroxychloroquine in combination with gemcitabine and nab-paclitaxel for advanced pancreatic cance…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) [Phase 3]
Phase 3 PANOVA-3 trial evaluated tumor treating fields (150 kHz) added to gemcitabine and nab-paclitaxel as front-line therapy for locally a…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]
Phase 3 trial comparing gemcitabine plus paclitaxel versus gemcitabine alone after FOLFIRINOX failure in metastatic pancreatic adenocarcinom…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate [Phase 2]
A Phase 2 clinical trial evaluating DZ-002, a heptamine carboxymethine dye conjugate, as maintenance therapy for metastatic pancreatic cance…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 trial of APG-1387 in combination with chemotherapy for advanced pancreatic adenocarcinoma has been terminated.